and through G2 to mitosis [3, [8] [9] [10] [11] . Although the evidence is enticing, there is as yet no direct demonstration that nuclear PIs can be hydrolysed to generate nuclear DAG. Previous data in murine erythroleukemia (MEL) cells have suggested that nuclear phosphoinositidase Cβ β1 (PIC-β β1) activity is important in the generation of nuclear DAG. Here, we demonstrate that the molecular species of nuclear DAG bears little resemblance to the PI pool and is unlikely to be generated directly by hydrolysis of these inositol lipids. Further, we show that there are in fact two distinct subnuclear pools of DAG; one that is highly disaturated and mono-unsaturated (representing more than 90% of the total nuclear DAG) and one that is highly polyunsaturated and is likely to be derived from the hydrolysis of PI. Analysis of these pools, either after differentiation or during cell-cycle progression, suggests that the pools are independently regulated, possibly by the regulation of two different nuclear phospholipase Cs (PLCs). 
hydrolysed with specific phospholipases and the DAG generated was phosphorylated to form PA, using a nonspecific DAG kinase, in the presence of 32 P-labelled ATP. This PA was then dimethylated and separated using argentation chromatography, which distinguishes different molecular species primarily on the basis of the number of double bonds that they contain. The DAG derived from nuclear PI was predominantly unsaturated, with over 70% of the total species containing two, four and five double bonds, whereas that derived from nuclear PC was predominantly mono-unsaturated and disaturated ( Figure 1a ). This pattern of saturation acts as a 'fingerprint', indicating from which precursor lipid the nuclear DAG is derived. Subsequent analysis of nuclear DAG showed that over 90% of the total species were disaturated or mono-unsaturated, showing that it cannot be derived solely from the hydrolysis of PI lipids, but is likely to be derived from a balance of de novo synthesis, hydrolysis of precursor lipids such as PC or PI, and the removal of DAG. We have also found this pattern of DAG in the nuclei of Swiss 3T3 cells and porcine endothelial cells (data not shown).
As previous data suggested that incubation of intact nuclei at 30°C generates DAG derived from the hydrolysis of PI [3] , we analysed DAG generation using argentation chromatography. A nuclear activity was able to generate DAG, but subsequent analysis revealed that this DAG species was highly mono-unsaturated. There was a decrease in the disaturated DAG that might have been due to a DAG lipase activity or to a desaturase activity; a desaturase activity could not, however, account for the increase in the other unsaturated lipids alone (a decrease of 50 with a comparable increase in the total DAGs of 1150 arbitrary values; Figure 1b , D609). This reaction was not inhibited by D609, (an inhibitor of PC-specific PLC [12] ), alkyllysophospholipids (ALP), U73122 (a PIC-specific inhibitor [13] ) or butanol (Figure 1b) . Indeed, in intact cells, butanol treatment did not lead to either the accumulation of nuclear phosphatidylbutanol (PB) or a decrease in nuclear DAG, suggesting that if a phospholipase D (PLD) activity was present, butanol was unable to act as a substitute for water in the transphosphatidylation reaction. No such activity was present in non-nuclear membranes. These data are consistent with the presence of a pool of nuclear DAG that is not derived from PI but may be derived from the hydrolysis of PC.
The above data did not show whether DAG could be derived from PI hydrolysis. Previously, it was demonstrated that PA can be generated in intact isolated nuclei in the presence of ATP, through the phosphorylation of the endogenous DAG by an endogenous nuclear DAG kinase [1, 2] . Argentation analysis of this PA showed that it was highly polyunsaturated (Figure 2a, lane 1) . This could occur if the nuclear DAG kinase has a specificity for polyunsaturated DAG or if this specific DAG is cocompartmentalised with the nuclear DAG kinase. Addition of exogenous DAG showed that the enzyme had no specificity even when the various species were added together and the products separated after the reaction (Figure 2a , lane 2). Moreover, disruption of the nuclei using deoxycholate and subsequent labelling of endogenous PA produced a species profile that was similar to the nuclear DAG profile previously described ( Figure 2a , lane 3).
Neither inhibitors of PLD nor inhibitors of PC-PLC had any effect on the in vitro labeling of PA (Figure 2b ). Two structurally different PIC inhibitors, U73122 and ALP, however, completely inhibited the production of nuclear PA (Figure 2b ), whereas the inactive analogue, U73343, had no effect (data not shown). These data demonstrate that there are two distinct pools of DAG in the nucleus, one of which is highly mono-unsaturated and disaturated and is not accessible to the nuclear DAG kinase. The second pool is highly polyunsaturated and the data are consistent with this being produced by a nuclear PIC, which, importantly, is able to utilise endogenous nuclear PIs. This second pool of DAG is then utilised directly by a co-compartmentalised DAG kinase to generate PA. These data also demonstrate that the production of labelled polyunsaturated PA in intact nuclei is a direct measure of the nuclear PIC activity using endogenous substrates.
The nuclear DAG levels in MEL cells during progression through the cell cycle or after differentiation were studied to establish whether these pools of DAG are independently regulated. Differentiation of these cells along the erythroid pathway leads to a decrease in the levels of nuclear DAG, suggested to occur through the downregulation of nuclear PIC-β1 activity [1, 2] . The data in Figure 3a , however, show that the decrease in nuclear DAG occurs predominantly through a decrease in the disaturated and the mono-unsaturated DAG (as these are the predominant species in control nuclei), showing that an inhibition of nuclear PIC activity cannot be the direct reason for this decrease (Figure 3a) . Although we and others [1, 2] have shown that nuclear PIC-β1 is downregulated after differentiation, and that when assayed with exogenous substrate the total nuclear PIC activity decreases, we found that, when assayed using intact nuclei and endogenous PI, the nuclear PIC activity remained unchanged (Figure 3b) . Analysis of the generation of nuclear DAG in intact nuclei showed that this activity was decreased by 50% after differentiation (Figure 3c ).
We then characterised changes in the nuclear DAG as a consequence of progression through the cell cycle. Nuclei were isolated at various time points after release from a (a) Analysis of nuclear DAG species. Nuclei were purified from MEL cells as described and a total lipid extract was isolated. The DAG was removed by chromatography on a neomycin column and the bound PC and PI were re-extracted from the column. The PC and PI were then hydrolysed using specific phospholipases and the DAG generated was phosphorylated to PA using a non-specific DAG kinase. The PA was analysed using argentation chromatography to reveal the saturation pattern of the DAG species. The data are presented as the percentage of the total DAG ± standard error of the mean (SEM) (n = 3). (b) Intact isolated nuclei are able to generate mono-unsaturated DAG. Nuclei were incubated either on ice or at 30 o C in the presence or absence of the various inhibitors. Nuclear DAG was extracted and phosphorylated to PA and analysed by argentation chromatography. The data are presented as the change in DAG species between nuclei that were incubated on ice and at 30°C. Data are shown ± SEM (n = 3). In (a,b) the numbers in the inset indicate the number of double bonds.
nocodazole block and either the DAG or the PIC activity in intact nuclei was assayed. No changes in either the levels of nuclear DAG or in the nuclear activity that generates mono-unsaturated and disaturated DAG were seen as cells progressed through the cell cycle (data not shown). In contrast to this, there was a threefold increase in the nuclear PA labelling 2 hours after release from the nocodazole block (Figure 4a ), which was completely Brief Communication 439 inhibited by pre-incubation with ALP ( Figure 4a ) or with U73122 (data not shown). Analysis of the DNA content showed that the cells were in G1 at this point. Species analysis of the increase in PA over the 4.5 hour time point, showed that more than 70% of the PA was highly polyunsaturated (Figure 4b ).
These data are consistent with the idea that nuclei contain two separate pools of DAG that are independently regulated to produce structurally distinct molecular species of DAG. The data strongly suggest that one of these pools is derived from the hydrolysis of PI lipids through the action of a PIC. The other pool of DAG is derived from various pathways, one of which may be through the action of a nuclear PC-specific PLC, as previously suggested [14] . As nuclear DAGs derived from various lipid precursors are different with respect to not only their structure but also their intranuclear localisation, this may represent a mechanism for the distinct spatial and temporal activation of specific isoforms of PKC within the nucleus.
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